Pharmacologic Actions: News and Research on Hypolipidemic Agents

MeSH tree: D27.505.954.557.500

Cholesterol crystals may trigger some liver disease

Cholesterol crystals in the liver may stiffen the organ early in those with metabolic dysfunction-associated steatotic liver disease (MASLD)—well before scarring develops—according to new research from a team in the Perelman ...

Experimental pill dramatically reduces 'bad' cholesterol

An experimental pill called enlicitide slashed levels of low-density lipoprotein (LDL) cholesterol, commonly known as "bad" cholesterol, by up to 60%, according to a new phase three clinical trial published in the New England ...

Statins emerge as potential cancer immunotherapy boosters

Cancer immunotherapy has transformed modern oncology by harnessing the body's own immune system to combat malignant disease. Immune checkpoint inhibitors targeting the PD-1/PD-L1 pathway have produced durable responses in ...

page 2 from 16